Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Successful Validation and Approval of the PapilloCheck HPV Test

Published: Wednesday, May 22, 2013
Last Updated: Wednesday, May 22, 2013
Bookmark and Share
The PapilloCheck HPV test from Greiner Bio-One GmbH has now received approval from the Dutch Society for Pathology.

Cervical cancer is one of the most frequent cancers among women. It is caused by a persistent infection involving certain types of human papillomaviruses (HPV). If this infection is detected at an early stage and the patient is given appropriate medical treatment, the development of cervical cancer can be prevented in virtually all cases. HPV tests, which detect the carcinogenic virus, therefore play a major role in cervical cancer screening.

Only HPV tests with a well-documented clinical performance and reproducibility should be used in the clinical management of cervical cancer. This is why guidelines such as those defined by a group of international experts led by Chris Meijer from the Free University of Amsterdam are essential. These guidelines describe the requirements for HPV-DNA tests and must be fulfilled by test providers.

The PapilloCheck HPV-DNA test from Greiner Bio-One enables the reliable detection and identification of 24 virus types (typing), thus ensuring realistic risk assessment for the patient. Its capabilities have already been demonstrated in several clinical studies. Two studies have now been conducted to evaluate the performance evaluation in terms of clinical sensitivity and specificity as well as inter- and intra-reproducibility in accordance with the specifications of international guidelines.

PapilloCheck met all the criteria that HPV tests need to fulfil for clinical use. In early 2013, the Dutch Society for Pathology followed this evaluation and granted PapilloCheck its approval. This is a milestone in performance evaluation of PapilloCheck and ultimately leads to safety for patients.

PapilloCheck® is part of the oCheck® product line from Greiner Bio-One GmbH.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!